Launched end of March 2006 this product combines an Excel company database
covering 209 private companies active in CNS & PNS drug research and
development with a full cross-referenced report in PDF format describing each
company in detail. Contact details, descriptive background information,
management team, investors and CNS/PNS drug pipeline are provided for all
entries. "A Survey of Private Companies Active in CNS & PNS Drug R&D" is by
far the most comprehensive survey of private players active in the neurology
market space available to this date. It is a must have report for everyone
professionally involved in CNS drug development and CNS drug development
companies.
Table of Contents
COMPANY DIRECTORY
Ablynx
Accera Pharmaceuticals
AC Immune
Acorda Therapeutics
ActivBiotics
Acumen Pharmaceuticals
Addex Pharmaceuticals
Aderis Pharmaceuticals
Aegera Therapeutics
Affectis Pharmaceuticals
AFFiRiS
AGY Therapeutics
Algos Therapeutics
Amsterdam Molecular Therapeutics
Apeiron Biologics
Arakis (Sosei Subsidiary)
Argolyn
ArmaGen Technologies
Asilomar Pharmaceuticals
Athersys
ATUKA
Auris Medical
Avera Pharmaceuticals
Axaron Bioscience
Axon Neuroscience
Azevan Pharmaceuticals
Bayhill Therapeutics
Berlex Laboratories (Schering Affiliate)
Bicoll
Bioalvo
Bioarctic Neuroscience
Bioaxone Therapeutic
Biocortech
Biofrontera AG
BiolineRX
BIOTECON Therapeutics (Analyticon Subsidiary)
Biovex
Boehringer-Ingelheim GmbH
Brainbits
Braincells
Brainsgate
Britannia Pharmaceutical (Forum Bioscience Subsidiary)
Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington's Disease Segment
